Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients
This change potentially allows access to Wegovy for just over 1 in 4 of the 13.7 million people on Medicare diagnosed with obesity or overweight, based on data from 2020, the analysis shows
The journal Science reports on the setback
Few human or murine studies exist regarding the influence of aging on susceptibility to drug induced liver injury 35 , which is often complicated by confounding factors including polypharmacy and genetics, among others
Most people start on a low dose to allow their digestive system to adapt
Whilst generally well-tolerated, like all medications, GLP-1 agonists carry potential side effects that patients and healthcare professionals should understand, including concerns about pancreatic safety that warrant careful consideration